Genzyme's Henri A. Termeer - CEO Pay

Henri A. TermeerHenri A. Termeer - Genzyme

Total Compensation: $13.8M

Details: Termeer received a cut in his overall compensation package from 2007's $14.6 million. However, he was awarded a $75,000 increase in his base salary, bringing it to $1,578,514. The value of his stock awards rose nearly $1.5 million, while the value of his option awards dropped from $10,040,452 to $7,791,889. 

Also included in Termeer's payment package was $115,502 in other compensation, including $73,599 for use of the company's car and driver. The rest went to matching contributions to his 401(k), life and disability insurance.

Genzyme News:
Genzyme's Myozyme approved
Genzyme gets biosimilar rejection, builds R&D plant
Genzyme gets public backing for $200M expansion
Genzyme wins Isis pact with $1.9B bid

Genzyme's Henri A. Termeer - CEO Pay
Read more on

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i